Related references
Note: Only part of the references are listed.Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30
Christian Kellner et al.
ONCOIMMUNOLOGY (2016)
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen et al.
CELL REPORTS (2016)
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity
Matthias Peipp et al.
ONCOTARGET (2015)
Effect of NKG2D ligand expression on host immune responses
Marine Champsaur et al.
IMMUNOLOGICAL REVIEWS (2015)
Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside
Mounia S. Braza et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
Dieter Kabelitz et al.
ONCOIMMUNOLOGY (2013)
Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors
Daniel V. Correia et al.
ONCOIMMUNOLOGY (2013)
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
Marta Coscia et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity
Christian Kellner et al.
JOURNAL OF IMMUNOLOGY (2012)
Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity
C. Kellner et al.
LEUKEMIA (2012)
Harnessing γδ T cells in anticancer immunotherapy
Dalil Hannani et al.
TRENDS IN IMMUNOLOGY (2012)
Human kappa light chain targeted Pseudomonas exotoxin A - identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development
C. Kellner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells
S. Stamova et al.
LEUKEMIA (2011)
Crystal structure of γδ T-cell receptor specific for the human MHC class I homolog MICA
Bin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
NKG2D Costimulates Human Vγ9Vδ2 T Cell Antitumor Cytotoxicity through Protein Kinase Cθ-Dependent Modulation of Early TCR-Induced Calcium and Transduction Signals
Steven Nedellec et al.
JOURNAL OF IMMUNOLOGY (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D
Yan Kong et al.
BLOOD (2009)
Natural killer and γδ T cells in haematological malignancies: enhancing the immune effectors
Jerome Rey et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Isopentenyl pyrophosphate-activated CD516+ γδ T lymphocytes display potent antitumor activity toward human squamous cell carcinoma
Alan A. Z. Alexander et al.
CLINICAL CANCER RESEARCH (2008)
NKG2D ligands in tumor immunity
N. Nausch et al.
ONCOGENE (2008)
V gamma 9V delta 2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas
Francoise Bouet-Toussaint et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Lysis of a broad range of epithelial tumour cells by human γδ T cells:: Involvement of NK62D ligands and T-cell receptor- versus NKG2D-dependent recognition
P. Wrobel et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Perspectives of gamma delta T cells in tumor immunology
Dieter Kabelitz et al.
CANCER RESEARCH (2007)
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo
EP von Strandmann et al.
BLOOD (2006)
In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model
H Sicard et al.
JOURNAL OF IMMUNOLOGY (2005)
Activation of Vγ9Vδ2 T cells by NKG2D
B Rincon-Orozco et al.
JOURNAL OF IMMUNOLOGY (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
MR Verneris et al.
BLOOD (2004)
Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas
JL Teeling et al.
BLOOD (2004)
Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid
A Poggi et al.
CANCER RESEARCH (2004)
Characterization of tumor reactivity of human Vγ9Vδ2 yδ T cells in vitro and in SCID mice in vivo
D Kabelitz et al.
JOURNAL OF IMMUNOLOGY (2004)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells
J Wu et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
V Groh et al.
NATURE IMMUNOLOGY (2001)
ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
D Cosman et al.
IMMUNITY (2001)
Share Paper
